Domain Therapeutics

Series-A
domaintherapeutics.com Biotech & Healthcare
Total Funding $41M
Latest Round $41M Series-A
Last Announced May 10, 2022
Investors Undisclosed
Decision Makers 6 Available

About Domain Therapeutics

Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website domaintherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @DOMAINtx (343 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $41,000,000 · Series-A

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Domain Therapeutics.

Funding History

1 Round
Series-A equity · May 10, 2022

Founders & Leadership

1

Neuville Pascal

CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts